Published in Proc Natl Acad Sci U S A on April 15, 1991
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A (1994) 3.24
DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A (1997) 3.03
De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol (1996) 2.26
Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol (2002) 2.24
Isolation and characterization of the cDNA encoding human DNA methyltransferase. Nucleic Acids Res (1992) 2.10
Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A (1993) 1.86
Connections between epigenetic gene silencing and human disease. Mutat Res (2007) 1.72
DNA methyltransferases: a novel target for prevention and therapy. Front Oncol (2014) 1.62
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Mol Cancer (2008) 1.60
Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. Proc Natl Acad Sci U S A (1993) 1.58
Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci U S A (1992) 1.56
Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol (1998) 1.48
Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc Natl Acad Sci U S A (1997) 1.48
Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene (2006) 1.46
DNA Electrochemistry Shows DNMT1 Methyltransferase Hyperactivity in Colorectal Tumors. Chem Biol (2015) 1.39
Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci U S A (1992) 1.34
DNA methylation: an alternative pathway to cancer. Ann Surg (2001) 1.24
Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways. Nucleic Acids Res (2003) 1.24
Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci U S A (1997) 1.19
DNA methylation and cancer diagnosis. Int J Mol Sci (2013) 1.18
DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair. Mol Cell Biol (2002) 1.18
The relationship between early embryo development and tumourigenesis. J Cell Mol Med (2010) 1.12
Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct Genomics (2013) 1.11
Aberrant promoter methylation of SPARC in ovarian cancer. Neoplasia (2009) 1.10
The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system. Br J Cancer (1998) 1.09
Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci U S A (1996) 1.05
DNA methylation: a phoenix rises. Proc Natl Acad Sci U S A (1993) 1.02
Concurrent replication and methylation at mammalian origins of replication. Mol Cell Biol (1998) 1.02
Differential expression of laminin receptors in human hepatocellular carcinoma. Gut (1998) 0.97
The expression of the follicle-stimulating hormone receptor in spermatogenesis. Recent Prog Horm Res (2002) 0.90
RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation. Cell Cycle (2014) 0.89
Neoplastic development: paradoxical relation between impaired cell growth at low population density and excessive growth at high density. Proc Natl Acad Sci U S A (1995) 0.86
Molecular mechanism of SLC5A8 inactivation in breast cancer. Mol Cell Biol (2013) 0.86
DNA methylation prevents the amplification of TROP1, a tumor-associated cell surface antigen gene. Proc Natl Acad Sci U S A (1994) 0.86
RGS6 suppresses Ras-induced cellular transformation by facilitating Tip60-mediated Dnmt1 degradation and promoting apoptosis. Oncogene (2013) 0.85
Incipient and overt stages of neoplastic transformation. Proc Natl Acad Sci U S A (1994) 0.85
Retinoblastoma pathway dysregulation causes DNA methyltransferase 1 overexpression in cancer via MAD2-mediated inhibition of the anaphase-promoting complex. Am J Pathol (2007) 0.84
Epigenetics in the hematologic malignancies. Haematologica (2014) 0.83
Correlation between the DNA global methylation status and progesterone receptor expression in normal endometrium, endometrioid adenocarcinoma and precursors. Virchows Arch (2004) 0.83
Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells. Mol Med Rep (2014) 0.82
Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest. PLoS One (2012) 0.81
Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape. Nat Rev Cancer (2016) 0.80
DNA Methylation in Basal Metazoans: Insights from Ctenophores. Integr Comp Biol (2015) 0.80
Spontaneously immortalised bovine mammary epithelial cells exhibit a distinct gene expression pattern from the breast cancer cells. BMC Cell Biol (2010) 0.78
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Neoplasia (2016) 0.77
RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer. AAPS J (2016) 0.76
Cytosine methyltransferases as tumor markers. Curr Genomics (2010) 0.76
The molecular genetics of colorectal carcinoma--knowledge for knowledge's sake? West J Med (1991) 0.75
DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. PLoS One (2015) 0.75
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
The clonal evolution of tumor cell populations. Science (1976) 24.39
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (1983) 9.28
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
The molecular genetics of cancer. Science (1987) 7.64
High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell (1990) 7.45
Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science (1988) 6.77
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol (1982) 6.11
DNA methylation and gene activity. Cell (1988) 5.90
Allelotype of colorectal carcinomas. Science (1989) 5.54
Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol (1988) 5.24
Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell (1989) 5.12
Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res (1985) 5.02
Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (1985) 3.72
Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol (1986) 3.61
The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res (1983) 3.51
Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res (1989) 3.35
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 3.03
Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01
Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science (1987) 2.52
De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci U S A (1990) 2.42
Review: assessment of cell proliferation in histological material. J Clin Pathol (1990) 2.41
Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun (1983) 2.41
Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology (1987) 2.39
Specific protection of methylated CpGs in mammalian nuclei. Cell (1989) 2.32
Genetics of human cancer. Annu Rev Genet (1986) 2.28
The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci U S A (1988) 2.14
Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature (1987) 2.14
Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res (1985) 2.12
The role of DNA methylation in cancer. Adv Cancer Res (1990) 2.09
Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res (1988) 1.93
Genetics of cancer predisposition. Cancer Res (1987) 1.78
DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem (1986) 1.72
Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med (1985) 1.58
DNA methylation and cancer. Cancer Res (1986) 1.47
DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res (1986) 1.43
Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood (1987) 1.39
Cell cycle-dependent regulation of eukaryotic DNA methylase level. J Biol Chem (1985) 1.17
Abnormal methylation of the calcitonin gene in human colonic neoplasms. Cancer Res (1989) 1.10
Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. J Clin Invest (1989) 0.98
The calcium signal for BALB/MK keratinocyte terminal differentiation counteracts epidermal growth factor (EGF) very early in the EGF-induced proliferative pathway. Mol Cell Biol (1988) 0.94
Patterns of DNA methylation and gene expression in human tumor cell lines. Cancer Res (1986) 0.92
Computational analysis of structural and energetic consequences of DNA methylation. Carcinogenesis (1989) 0.89
Biomarkers of increased susceptibility to gastrointestinal cancer. Their development and application to studies of cancer prevention. Gastroenterology (1987) 0.89
Risk factors and preventive measures in the control of cancer of the large intestine. Curr Probl Cancer (1980) 0.81
Sodium transport in a mouse model of colonic carcinogenesis. Cancer Res (1987) 0.79
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A (1996) 29.54
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med (2000) 12.34
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A (1998) 9.66
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet (1999) 9.53
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med (1995) 9.10
A gene hypermethylation profile of human cancer. Cancer Res (2001) 8.93
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 8.34
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res (1995) 7.42
Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (1987) 7.12
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun (1985) 6.57
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst (2000) 6.38
Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science (1991) 6.15
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet (2000) 5.72
Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Allelotype of colorectal carcinomas. Science (1989) 5.54
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res (1995) 5.11
Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
Bias in treatment assignment in controlled clinical trials. N Engl J Med (1983) 4.78
The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med (1997) 4.66
Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature (1990) 4.62
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol (1994) 4.43
Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res (1998) 4.39
Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res (1987) 4.25
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet (1995) 4.01
Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A (1998) 3.80
Clonal analysis of human colorectal tumors. Science (1987) 3.72
Hypomethylation of DNA from benign and malignant human colon neoplasms. Science (1985) 3.72
Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68
Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res (2000) 3.65
The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59
Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992) 3.58
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci U S A (2001) 3.51
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res (1996) 3.50
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res (1999) 3.48
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem (2001) 3.23
Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res (1994) 3.18
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res (1997) 3.17
Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res (1999) 3.15
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res (1995) 3.13
Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res (1997) 3.09
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res (2000) 2.99
Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem (2000) 2.97
Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology (1982) 2.95
CpG methylation is maintained in human cancer cells lacking DNMT1. Nature (2000) 2.94
Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst (2001) 2.93
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med (1998) 2.91
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
The ovalbumin gene is associated with the nuclear matrix of chicken oviduct cells. Cell (1982) 2.86
Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res (2001) 2.79
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res (2000) 2.79
Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67
Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res (1999) 2.62
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood (1999) 2.57
Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol (1997) 2.57
Mad-related genes in the human. Nat Genet (1996) 2.51
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science (1985) 2.49
p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med (1995) 2.47
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res (1994) 2.39
Methylation-specific PCR simplifies imprinting analysis. Nat Genet (1997) 2.33
The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol (1987) 2.31
Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]. JAMA (1989) 2.29
An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature (1997) 2.29
Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem (1997) 2.27